We monitor the latest findings on pharmaceutical safety, focusing on emerging links between GLP-1 medications and optic nerve complications.
NAION Optic Nerve Risk
Emerging Clinical Data
Pharmaceutical Accountability
Recent studies investigate the connection between GLP-1 receptor agonists and non-arteritic anterior ischemic optic neuropathy (NAION).
Our team reviews peer-reviewed data and adverse event reports to identify patterns of vision loss in affected patients.
We believe drug manufacturers must be held accountable for potential side effects not adequately disclosed to patients.
Dedicated to Justice and Patient Advocacy
Tosi Law provides clear legal guidance, ensuring zero upfront costs unless we secure compensation on your behalf.
Our Straightforward Review Process
Confidential Inquiry
Medical History Review
Legal Grounds Assessment
Pursue Accountability
Share your experience with us securely. Your initial case evaluation is completely confidential.
We'll review your GLP-1 prescription details and vision diagnosis with our medical experts.
Our attorneys will determine if you have grounds for a lawsuit based on current clinical research.
If your case is viable, we will represent you in seeking financial recovery from responsible parties.
Your vision matters. Contact us today for a free, no-obligation review of your potential GLP-1 claim.